EIPWL / East India Pharma Works IPO Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 16, 2022Let’s have a detailed review of the company and analytics of the EIPWL / East India Pharma IPO release date, IPO offer price, subscription, EIPWL / East India Pharma Works IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs [●] |
| Listing At | BSE, NSE |
| Min. Order Quantity | NA |
| Listing Date | NA |
| Offer for Sale | Rs Million |
| Fresh Issue | Rs Million |
| IPO Size | Rs Million |
| Tick Size | 1 |
EIPWL / East India Pharma IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
| EIPWL / East India Pharma Share Price – Live Performance |
EIPWL / East India Pharma IPO – Summary
An inclusion into the world of Pharma was East India Pharma back in the year 1936, which directed East India Pharma into the fraternity of one of the oldest players in the industry.
The company was focused into providing and catering for the needs of millions. They synthesize modern drugs which are created from the basic chemicals, while doing the same through private entrepreneurship of great visionaries.
EIPWL / East India Pharma IPO Date
The opening and the closing date of the IPO of EIPWL / East India Pharma Limited are not available yet.
EIPWL / East India Pharma IPO Subscription
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – | ||||
| 2nd Day – | ||||
| 3rd Day – | ||||
| Shares Offered or Net Issue |
The shares subscribed by the public will be updated here.
Check EIPWL / East India Pharma IPO LIVE Subscription
- EIPWL / East India Pharma IPO LIVE Bid details on BSE
- EIPWL / East India Pharma IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
EIPWL / East India Pharma IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
EIPWL / East India Pharma Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | – |
| Refunds Initiation | – |
| Credit of Shares to Demat Account | – |
| Share Listing Date | – |
EIPWL / East India Pharma IPO Price Band / Cash Price
The face value of each share is Rs.10, but the price band of the IPO is Rs.[●]
EIPWL / East India Pharma IPO Equity Size
This Initial Public Issue of 18,24,000 Equity Shares of Rs.10 each for cash at a price of Rs.[●] per equity share aggregating to Rs.[●] Million.
EIPWL / East India Pharma IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] equity Shares of Rs.10/ each.
Issue Size: X Equity Shares of Rs.10 each, aggregating to Rs.[●] Million
Open Free Demat Account Now!
EIPWL / East India Pharma IPO – Live Performance
The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – EIPWL / East India Pharma Share Price |
EIPWL / East India Pharma IPO Grey Market Premium
The EIPWL / East India Pharma Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X.
EIPWL / East India Pharma IPO – Company Overview
East India Pharma has embarked into a great journey, and now has established as large pharmaceutical company. The company possess 2 manufacturing units, which are run by a total number of 1400 employees.
Both the facilities together, account for the company, an annual turnover of around Rs.1300 million. Quality has been the factor this company relies on and hence, they have adhered to the high standard, most modern equipment, trained personnel and also state of art R&D facility.
Their working nature and fashion, have fetched them the ISO 9001-2015 Certification and GMP Certification. Furthermore, this company generates revenue for 350 well trained field personnel, 17 sales offices, channel partners and a large number of approved wholesalers.
EIPWL / East India Pharma IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Million) | ||||
| 30-Jun-20 | 31-Mar-20 | Mar-19 | 31-Mar-18 | |
| Total Assets | ||||
| *Total Revenue | ||||
| Total Expense | ||||
| Profit After Tax | ||||
Earnings per Equity Share (in Million)
| 30-Jun-20 | 31-Mar-20 | Mar-19 | 31-Mar-18 |
|
| Basic & Diluted |
Further, their PAT for the period ended on June 30, 2020, March 31, 2020, March 31, 2019, and March 31, 2018, were Rs. 135.51 Million, Rs. 447.45 Million, Rs. 68.04 Million and Rs. 26.91 Million respectively.
EIPWL / East India Pharma IPO – Promoters
The Promoter of this company is:
List of Related Parties (Key Managerial Personnel)
- Mr. Manish Kumar Dabkara, Chairman & Managing Director
- Mr. Naveen Sharma, Chief Financial Officer
- Mr. Babita Kumawat, Company Secretary and Compliance Officer
EIPWL / East India Pharma IPO – Promoters Holding
- Pre Issue Share Holding – %
- Pos Issue Share Holding – %
EIPWL / East India Pharma IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.[●] Million |
| of which: | |
| Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | X Equity Shares |
| Equity Shares outstanding after the Issue | X Equity Shares |
EIPWL / East India Pharma IPO Issue Object
Their Company proposes to utilise the Net Proceeds towards funding the following objects:
1. To meet Working Capital requirements
2. General Corporate Purpose
3. To meet issue expenses
EIPWL / East India Pharma IPO – Business Strategy
- Focus on Consultancy Business and spreading awareness about carbon neutrality
- Increase the use of technology to improve operational efficiency
- Expanding their customer base
- Creating awareness to reduce carbon emissions
EIPWL / East India Pharma IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Quality Assurance, timely payment, and delivery
- Broad customer base and strong relationships with their customers
- Multiple Business verticals under one roof
- Qualified management team and employee base
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-20 | |||
| 31-Mar-19 | |||
| Mar-18 |
EIPWL / East India Pharma IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Crores) | |
| EIPWL / East India Pharma Limited | 10 | [●] | 8.86 | 73.11 | 20.43 |
| Listed Peers | |||||
| Mitcon Consultancy and Engineering Services Limited |
10 | 12.46 | 3.13 | 3.91% | 42.72 |
EIPWL / East India Pharma IPO Lead Managers
| Lead Managers |
EIPWL / East India Pharma IPO Registrar to offer
| Registrar to the Offer |
| BIGSHARE SERVICES PRIVATE LIMITED Address:-1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai – 400059 Tel No.:+91-022-62638200 Fax No.: +91-022-62638299 Website:www.bigshareonline.com Email:ipo@bigshareonline.com Investor Grievance Email: investor@bigshareonline.com |
EIPWL / East India Pharma IPO – Other Details
- Statutory Auditor – NA
- Legal Counsel to the Company – NA
- Bankers to the Company – NA
EIPWL / East India Pharma IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to EIPWL / East India Pharma IPO
EIPWL / East India Pharma Limited IPO News
News 1 – EIPWL / East India Pharma Limited IPO DRHP Download
News 2 – EIPWL / East India Pharma IPO RHP Download
EIPWL / East India Pharma IPO Review FAQs
Ques – What is the Issue Size of EIPWL / East India Pharma IPO?
Answer – The Company is making an initial public offer of NA equity shares. We vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and the net issue.
Ques – What is the Price band of EIPWL / East India Pharma IPO?
Answer – The price band for this particular IPO, i.e. EIPWL / East India Pharma IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.10 per share.
Ques – What is the EIPWL / East India Pharma IPO Open Date?
Answer – The opening and closing dates for EIPWL / East India Pharma IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
Ques – What is the EIPWL / East India Pharma IPO Allotment Date?
Answer – We also have the news regarding the respective allotment dates of EIPWL / East India Pharma IPO. Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
Ques – What is the EIPWL / East India Pharma IPO Listing Date?
Answer – Shares of EIPWL / East India Pharma shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Ques – Who is the Registrar of EIPWL / East India Pharma IPO?
Answer – One of the reputed registrars is managing the issue of EIPWL / East India Pharma IPO, i.e. Bigshare Services Private Limited. Their website will help you regarding the further information you are on the lookout for.
Ques – Who is the Promoter of EIPWL / East India Pharma IPO?
Answer – Here are the promoters of EIPWL / East India Pharma – NA. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
Ques – What is GMP of EIPWL / East India Pharma IPO?
Answer – We have obtained the GMP of EIPWL / East India Pharma IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Ques – Is EIPWL / East India Pharma IPO good for Investment?
Answer – We have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
Ques – What is the PAT of EIPWL / East India Pharma Company?
Answer – We have the information of company financials, and according to that, we have the figures from the last few years to provide. PAT for the financial year 2020 in Million is NA, 2019 is NA, 2018 is NA. PAT from Sep 2020 is NA.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Market Guide
Featured Topics